Abbott Laboratories (ABT) Divestments (2015 - 2021)

Abbott Laboratories' Divestments history runs 5 years deep, the most recent figure standing at $86.0 million for Q3 2021.

• In Q3 2021, Divestments changed N/A year-over-year to $86.0 million; the TTM figure through Dec 2022 stood at $86.0 million (down 10.42% YoY), while the FY2024 annual figure was $1.0 million, down 97.5% from the prior year.
• Divestments came in at $86.0 million for Q3 2021 at Abbott Laboratories, up from $10.0 million in the prior quarter.
• In the past five years, Divestments ranged from a high of $1.7 billion in Q1 2017 to a low of -$29.0 million in Q3 2017.
• A 3-year average of $391.8 million and a median of $48.0 million in 2020 frame the typical range for Divestments.
• On a YoY basis, Divestments climbed as much as 6640.0% in 2017 and fell as far as 6640.0% in 2017.
• Abbott Laboratories' Divestments stood at $600.0 million in 2017, then sank by 98.33% to $10.0 million in 2020, then soared by 760.0% to $86.0 million in 2021.
• According to Business Quant data, Divestments over the past three periods registered $86.0 million, $10.0 million, and $600.0 million for Q3 2021, Q4 2020, and Q4 2017 respectively.

Peer Comparison